Informação sobre produto
- 3,5,7-Trihydroxy-4'-methoxyl-8-prenylflavone-3-O-rhamnopyranoside
- 3-[(6-Deoxy-α-<span class="text-smallcaps">L</span>-mannopyranosyl)oxy]-5,7-dihydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-4H-1-benzopyran-4-one
- 4H-1-Benzopyran-4-one, 3-((6-deoxy-alpha-L-mannopyranosyl)oxy)-5,7-dihydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-butenyl)-
- 4H-1-Benzopyran-4-one, 3-[(6-deoxy-α-<span class="text-smallcaps">L</span>-mannopyranosyl)oxy]-5,7-dihydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-
- 4H-1-Benzopyran-4-one, 3-[(6-deoxy-α-<span class="text-smallcaps">L</span>-mannopyranosyl)oxy]-5,7-dihydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-butenyl)-
- 5,7-dihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-en-1-yl)-4-oxo-4H-chromen-3-yl 6-deoxy-alpha-L-mannopyranoside
- Baohuoside 1
- Baohuside I
- Icariin II
- Icariside II
- Ver mais sinónimos
Icarisid II is a drug that has been shown to have an effect on postprandial blood glucose levels. It is used as a control method for the prevention and treatment of squamous cell carcinoma. Icarisid II also inhibits the expression of toll-like receptor 4, which plays an important role in maintaining homeostasis in the body and inhibiting tumor growth. Icarisid II was found to be more effective than icariside when combined with baohuoside for treating melanoma cells. Icarisid II may also act as an EGFR inhibitor and apoptosis pathway activator, enhancing its antitumor activity.
Propriedades químicas
Consulta técnica sobre: 3D-FI73956 Icarisid II
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
